...
首页> 外文期刊>Carcinogenesis >FBXW10 promotes hepatocarcinogenesis in male patients and mice
【24h】

FBXW10 promotes hepatocarcinogenesis in male patients and mice

机译:FBXW10促进男性患者和小鼠的肝癌发生

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatocellular carcinoma (HCC) is reported to associate with abnormal expression of SCF E3 ubiquitin ligases. FBXW10, an F-box protein of the E3 ubiquitin ligases, was abnormally regulated in HCC patients. However, whether FBXW10 is associated with HCC has not yet been evaluated. Here, we analyzed the associations between overall survival and various risk factors in 191 HCC tissues. Univariate and multivariate analyses demonstrated that FBXW10 was an independent risk factor related to HCC prognosis. The results showed that FBXW10, gender and tumor state were strongly associated with overall survival in HCC patients. Furthermore, high expression of FBXW10 was associated with poor survival among male HCC patients but not female HCC patients. FBXW10 was more highly expressed in male HCC tissues and more strongly related to vascular invasion in male HCC patients. Consistent with these findings, the male FBXW10-Tg(+) mice were more susceptible to tumorigenesis, changes in regenerative capacity, and liver injury and inflammation but not changes in liver function than FBXW10-Tg(-) mice. FBXW10 promoted cell proliferation and migration in HCC cell lines. Our findings reveal that FBXW10, an independent risk factor for HCC, promotes hepatocarcinogenesis in male patients, and is also a potential prognostic marker in male patients with HCC.
机译:据报道,肝细胞癌(HCC)与SCF E3泛素连接酶的异常表达相关联。 FBXW10,HCC患者异常调节E3泛素连接酶的F-Box蛋白。但是,尚未评估FBXW10是否与HCC相关联。在这里,我们分析了191个HCC组织的总生存期和各种风险因素之间的关联。单变量和多变量分析证明FBXW10是与HCC预后有关的独立危险因素。结果表明,与HCC患者的总生存率强烈有关FBXW10,性别和肿瘤状态。此外,FBXW10的高表达与雄性HCC患者的存活率不佳,但不是女性HCC患者。 FBXW10在雄性HCC组织中更高度表达,与雄性HCC患者的血管侵袭更强烈相关。与这些发现一致,雄性FBXW10-Tg(+)小鼠更容易受到肿瘤发生,再生能力的变化,以及肝损伤和炎症而不是肝功能而不是FBXW10-TG( - )小鼠的变化。 FBXW10促进了HCC细胞系中的细胞增殖和迁移。我们的研究结果表明,HCC的独立危险因素,HCC的独立危险因素促进了男性患者的肝癌发生,也是HCC患者的潜在预后标志物。

著录项

  • 来源
    《Carcinogenesis》 |2020年第5期|共10页
  • 作者单位

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

    Third Mil Med Univ Army Med Univ Inst Hepatobiliary Surg Southwest Hosp Key Lab Hepatobiliary &

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号